Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0028754 (obesity)
 124,988 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Diabetes is associated with changes in plasma lipids and lipoproteins into atherogenic direction. In IDDM these changes are small or absent if good metabolic control can be maintained. Diabetic nephropathy is, however, associated with the appearance of dyslipoproteinemia. In NIDDM plasma total and VLDL triglyceride levels are elevated, and HDL-cholesterol level is decreased, and this pattern of dyslipoproteinemia does not always respond to improved control of hyperglycemia. Abnormalities of lipoprotein metabolism, not reflected in conventional plasma lipid and lipoprotein level measurements, and glucosylation of lipoproteins and resulting alterations in lipoprotein catabolism may be of importance in the enhanced atherogenesis in diabetes. Both IDDM and NIDDM are associated with an increased frequency of hypertension, but the underlying mechanisms appear to be different. In IDDM hypertension is usually associated with the development of diabetic nephropathy and thus with a long duration of the disease. In NIDDM hypertension is often present already at the time of diagnosis, and also in IGT, the precursor stage of NIDDM, the prevalence of hypertension is already increased. Obesity explains only in part the high prevalence of hypertension in patients with NIDDM. Diabetes is known to be associated with multiple abnormalities in hemostatic factors and, although these abnormalities may contribute importantly to the increased risk of ASVD in diabetic patients, information about their real role is scanty and conflicting. The impact of general major risk factors for ASVD, elevated plasma cholesterol, elevated blood pressure, and smoking, on the risk of ASVD appears to be similar in diabetics and nondiabetics. Only a relatively small proportion of the excessive occurrence of ASVD in diabetics can, however, be explained by the effects of diabetes on the levels of general risk factors for ASVD. This proportion mediated through the effects of diabetes on risk factors is larger in female diabetics than in male diabetics. The major proportion of the excess of ASVD in diabetics remains, however, unexplained and must be due to effects of diabetes itself through mechanisms that are incompletely understood.
 ...
PMID:Diabetes and atherosclerosis: an epidemiologic view. 355 30

Mexican Americans have a higher prevalence of NIDDM, more overall obesity and more centralized adiposity than non-Hispanic whites, but have thus far not been characterized as to whether they have greater upper body adiposity. Waist-to-hip circumferences (WHR, a measure of upper body adiposity) and subscapular-to-triceps skinfold ratios (centrality index, a measure of centralized adiposity) were determined in 725 Mexican Americans and 226 non-Hispanic whites as part of the San Antonio Heart Study, a population-based study of diabetes and cardiovascular risk factors. Mexican American females had higher centrality indices and WHRs than non-Hispanic white females, even after adjustment for demographic (age, menopausal status) and behavioral variables (body mass index, parity, cigarette smoking, alcohol consumption, exercise, and oral contraceptive and estrogen use). Mexican American males had higher centrality indices than non-Hispanic white males, but differences in WHR disappeared after adjustment for overall adiposity (body mass index). Of the demographic and behavioral variables, only age and body mass index were consistently related to regional body fat distribution. The lack of an association between body fat distribution and behavioral variables suggests that genetic factors may play the principal role in determining body fat distribution. Surprisingly, the distributions of centrality index and WHR were relatively independent of one another suggesting that they may be used as distinct, independent predictors of metabolic diseases.
 ...
PMID:Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. 380 66

A comparison of 148 newly diagnosed ('incident') and 202 previously diagnosed ('prevalent') Nauruan diabetics, examined during a population survey in 1982, has permitted cautious inference regarding the natural history of non-insulin-dependent diabetes (NIDDM) in this Micronesian population. As might be expected the results of the comparison do suggest that Nauruan diabetics undergo further deterioration in glucose tolerance, subsequent to diagnosis of the disease. Plasma glucose concentration is higher in prevalent than incident cases (males: fasting--12.2 versus 10.4 mmol/l; 2 h--18.9 versus 16.3 mmol/l; and females: fasting--13.1 versus 9.3 mmol/l; 2 h--20.3 versus 15.8 mmol/l) suggesting that present treatment measures may not be effective in this population. There was also some evidence that the metabolic consequences of NIDDM may be greater in female than in male Nauruans. Apart from plasma glucose concentration, of 8 other biological variables examined by univariate and multiple logistic regression analysis, three showed consistent differences between incident and prevalent cases in females, but none were consistently different in males. A relatively small difference in estimates of obesity was observed between incident and prevalent cases, and this was particularly notable in males. A number of potential sources of bias in this study are highlighted, and definitive, longitudinal studies will be required to corroborate these findings.
 ...
PMID:Non-insulin-dependent diabetes in Nauruans: a comparison of newly and previously diagnosed cases. 383 5

A polymorphic region 5' to the human insulin gene has been associated with diabetes in earlier studies. This polymorphic region is composed of tandem repeats that fall into 3 general size classes, designated class 1 (600 base pairs), class 2 (1300 base pairs), and class 3 (2500 base pairs). Frequencies of these classes of alleles vary among racial groups. American Blacks have been underrepresented in published studies of insulin gene polymorphism and diabetes. We undertook a cooperative study between two centers (San Francisco and St. Louis) to determine geno-types at the insulin locus in 313 unrelated American Blacks (132 nondiabetic, 27 with IDDM, and 154 with NIDDM). In both centers, nondiabetic individuals were younger and leaner than NIDDM patients. Allelic and genotypic frequencies at the insulin locus were not different between the two centers. Class 1 alleles represented 60% of all alleles, class 2 alleles 11%, and class 3 29%. No class of insulin allele was associated with NIDDM in this study. Subdivision of the study population by obesity, family history, or age at diagnosis failed to detect a subgroup for which the insulin allele was associated with NIDDM. Only 27 IDDM individuals were studied, and no significant association of class 1 alleles with this group was noted. However, examination of more IDDM individuals is required before a definitive statement can be made. Fasting serum triglyceride levels were determined retrospectively in 50 NIDDM individuals. No differences in triglyceride levels among genotypes were noted. The frequency of class 3 alleles in 13 hypertriglyceridemic NIDDM subjects was not different from that of the whole group.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Lack of association of the polymorphic locus in the 5'-flanking region of the human insulin gene and diabetes in American blacks. 388 60

The heterogeneity within Type II diabetes (NIDDM) and within Maturity-Onset type Diabetes of Young people (MODY), a subset of NIDDM which is inherited in an autosomal dominant fashion, is discussed. Aspects of the definition and phenotypic expression of MODY are reviewed. Within NIDDM there are differences in patterns of inheritance between subgroups. HLA antigen associations are not found in most NIDDM populations but exist in three specific population groups with Type II diabetes. Within NIDDM and within MODY there are differences in the magnitude of insulin responses to glucose, differences in target tissue responsiveness to insulin in vivo, and differences in receptor and post-receptor effects of insulin. Structurally abnormal variant and biologically defective insulin molecules have been found in some Type II diabetic patients and in members of certain MODY families. The presence or absence of obesity may mark heterogeneous groups of Type II diabetic patients, in addition to the importance of obesity in uncovering an insulin secretory defect by causing insulin resistance. There is heterogeneity in susceptibility to vascular disease within NIDDM and MODY. The natural history of carbohydrate metabolism and of insulin secretory responses to glucose in early Type I diabetes and in MODY with low insulin secretory responses are illustrated and similarities and dissimilarities compared and contrasted. Failure to recognize young patients with MODY may contribute to incorrect diagnosis, management, and assignment of prognosis of this form of diabetes in the young by many practicing physicians. The recognition that Type I or insulin-dependent diabetes (IDDM) and Type II or noninsulin-dependent (NIDDM) differ from each other not only phenotypically but also in etiology and pathogenesis led the National Diabetes Data Group (NDDG) to devise the present nomenclature and classification of diabetes mellitus. These were adopted by the World Health Organization. As suggested by the NDDG report, the classification should be reexamined periodically to reflect improved understanding of the disease, to stimulate further research, and to be of help to practicing physicians.
 ...
PMID:Heterogeneity within type II and MODY diabetes. 389 67

Serum gastric inhibitory polypeptide (GIP), insulin, and glucose responses to either a 75-g oral glucose challenge or a 500-cal liquid test meal were determined in 141 Caucasians and American Indians. The Caucasians were normal weight, averaging 101 +/- 3% (+/-SEM) ideal BW (IBW), or were obese (168 +/- 21% IBW) and had normal glucose tolerance (n = 77), impaired glucose tolerance (IGT; n = 12), or noninsulin-dependent diabetes mellitus (NIDDM; n = 19). The American Indians were all obese (144 +/- 6% IBW) and had either normal glucose tolerance (n = 22) or NIDDM (n = 11). In all study subjects, including obese individuals with and without glucose intolerance, diabetic patients both thin and obese, and lean subjects with impaired glucose tolerance, fasting serum insulin and GIP, and incremental glucose, insulin, and GIP were greater than they were in normal lean subjects, especially during the first hour of the tests. Obese subjects and diabetic patients exceeded lean normal subjects by up to 620% for glucose, up to 640% for insulin, and up to 360% for GIP during the first hour after glucose ingestion or the test meal. Exceptions were two groups with the most severe diabetes in whom incremental insulin values after oral glucose were only 70% (thin Caucasians) and 110% (obese Indians) that of lean normal subjects. The smallest differences in GIP responses occurred between lean normal subjects and obese nondiabetic Caucasians tested with either a meal or oral glucose, whereas American Indians consistently had the greatest insulin and GIP responses to the tests. High fasting GIP and exaggerated GIP increments in response to nutrients could be attributed to neither obesity nor diabetes alone nor to the type of nutrient used to stimulate its release, but, instead, may be genetic or dietary in origin or may be due to other as yet unidentified factors. High basal GIP and exaggerated nutrient-stimulated GIP release were associated with hyperinsulinemia, except in the most severe diabetic patients. These observations suggest that exaggerated GIP release, along with a greater rise in serum glucose in response to nutrients, may play a role in the pathogenesis of the hyperinsulinemia of obesity and early NIDDM.
 ...
PMID:Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus. 400 8

Refinement of the classification of diabetes mellitus to include two major categories, insulin dependent (IDDM) and noninsulin-dependent (NIDDM) and the recent attention paid to the standardization of epidemiological techniques have led to much new information on the epidemiology of the disease. Support for the notion of genetic influence in the development of NIDDM has come from twin studies, but the search for specific genetic markers for NIDDM has been largely unproductive to date. There is increasing scepticism as to the utility of the chlorpropamide-alcohol flush as a genetic marker for NIDDM. The large disparity in the frequency of NIDDM between populations provides indirect support for the genetic hypothesis, as do recent studies of the association between NIDDM and ancestral genetic admixture. Obesity has long been considered a causal factor in the aetiology of NIDDM, though the strength and consistency of this relationship is now being questioned. The strength of the association between obesity and NIDDM has been shown to vary depending on the presence or absence of a family history of the disease. There is further preliminary evidence to suggest that association between obesity and NIDDM may vary in strength between populations, and between the sexes. Little evidence has so far emerged for a role of quantitative or qualitative aspects of diet in the aetiology of NIDDM. This may be due, in part, to the imprecision of current techniques for dietary estimation.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:Genetic and environmental influence in the epidemiology of noninsulin-dependent diabetes mellitus: a global perspective. 403 96

To assess the effects of very low caloric (VLC) diets on glucose homeostasis in noninsulin-dependent diabetes mellitus, 30 obese subjects with NIDDM were studied for 40 days while eating a 330 Cal/day diet, with a subgroup of 12 subjects further evaluated during 40 days of refeeding. All subjects successfully lost weight, with an average weight loss of 4.6 +/- 0.2 kg (+/- SEM) after 10 days, 7.1 +/- 0.3 kg after 20 days, and 10.5 +/- 0.4 kg after 40 days of VLC diet therapy. Thus, weight loss was steady and progressive throughout the diet period. In contrast, the majority (87%) of the reduction in mean fasting plasma glucose (FPG) levels (297 +/- 13 to 158 +/- 10 mg/dl; P less than 0.001) occurred after 10 days of VLC diet therapy, with a further reduction in glucose levels to 138 +/- 9 mg/dl on day 40. The FPG response measured after 10 days of VLC diet was unrelated to the degree of obesity, rate or extent of weight loss, or prevailing insulin levels, but did correlate significantly with the initial FPG level (r = 0.37; P less than 0.05) and duration of diabetes (r = 0.42; P less than 0.05). After discontinuation of the VLC diet and refeeding of an isocaloric (weight maintenance) diet in 12 subjects, a variable increase in the FPG occurred, with an average increase of 80% after 40 days of refeeding. However, the mean FPG level after 40 days of refeeding was still markedly lower than that before VLC diet therapy (254 +/- 20 vs. 167 +/- 14 mg/dl; P less than 0.02) despite withdrawal of antidiabetic medication in all subjects. The basal hepatic glucose output (HGO) fell rapidly from 149 +/- 13 to 81 +/- 5 mg/M2 X min (P less than 0.001) after 10 days of VLC diet and rose from 67 +/- 4 to 88 +/- 7 mg/M2 X min (P less than 0.001) after 10 days of refeeding. Basal HGO demonstrated a highly significant positive correlation with FPG levels (r = 0.89; P less than 0.001) before and during both VLC diet therapy and refeeding. A significant correlation was also found between the change in FPG level and the change in basal HGO (r = 0.84; P less than 0.001) during both VLC diet and refeeding. Compared to that before the VLC diet, glucose tolerance to mixed meals was markedly improved during the refeeding period, with no change in circulating insulin levels.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. 404 80

The pathogenesis of the abnormal metabolic state in patients with non-insulin-dependent diabetes (NIDDM) is controversial. Even the term NIDDM stirs controversy because of the easily drawn inference that individuals with this form of diabetes do not need insulin treatment. Yet many patients with NIDDM are treated with insulin; some even develop hyperosmolar coma if not given insulin. Ketoacidosis, however, is very infrequent in this syndrome, implying that these patients are not dependent on insulin treatment to prevent mass mobilization of fatty acids and ketone bodies. The phrase noninsulin-dependent is therefore appropriate when used in this restricted fashion but inappropriate when used to imply adequacy of insulin secretion. The evaluation of the adequacy of islet function in this syndrome has been complex, since there is no standard of insulin output that can be defined for normal islets without specifying the physiologic setting under which the assessment has been made. For example, individuals with normal glucose levels but variable degrees of obesity have widely varying insulin secretion rates. Thus, the choice of controls is critical when comparing islet function in NIDDM to normal. In addition, the efficiency of the B-cell response to a challenge (e.g., oral glucose tolerance test) can markedly influence the magnitude of the stimulatory glucose level during the period of testing. For example, a subject with some impairment of insulin output will tend to become more hyperglycemic during the test. The hyperglycemia may then stimulate more insulin secretion so that the overall insulin output may appear equal to or even greater than that of a normal individual. In such a closed-loop system, strict control of input variables is necessary to evaluate whether or not insulin secretion is normal. As will be discussed, control of glucose level and other variables is seldom accomplished in dynamic glucose tolerance tests. As will be presented in this review, the development of appropriately controlled studies of islet function has provided convincing evidence that islet B-cell function is abnormal in patients with NIDDM. Since these studies are based on an understanding of normal islet function, normal islet B-cell physiology is discussed before pathophysiology. Finally, the implications of this analysis for the treatment of NIDDM with diet, hypoglycemic sulfonylureas, and insulin will be discussed.
 ...
PMID:Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. 609 29

Young African and Indian patients (age of onset under 35) were studied in order to determine the pattern of diabetes mellitus seen in these groups. Of the 110 African patients 86 had IDDM and 18 NIDDM, whereas of the 101 Indian patients the distribution was 40 and 60 respectively. Tropical diabetes (J-type and Z-type) was rare in both groups. IDDM tended to start at an earlier age in Indians (mean 17 years) compared to Africans (mean 23 years). Onset of the disease tended to be more frequent in winter, particularly in Indian patients. NIDDM was associated with a female predominance (3:1) and obesity in both population groups. A positive family history of diabetes mellitus was obtained from 80% of the Indian and 39% of the African patients with NIDDM.
 ...
PMID:Patterns of diabetes mellitus in young Africans and Indians in Natal. 633 96


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>